BioStem Technologies to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024
August 05, 2024 08:00 ET
|
Biostem Technologies
BioStem Technologies to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024
BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers
July 10, 2024 07:15 ET
|
Biostem Technologies
BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers
BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study
June 26, 2024 08:30 ET
|
Biostem Technologies
BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study
BioStem Technologies to Sponsor MRO Better Half Dash
May 29, 2024 11:00 ET
|
Biostem Technologies
BioStem Technologies to Sponsor MRO Better Half Dash
BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million
May 14, 2024 16:01 ET
|
Biostem Technologies
BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
May 07, 2024 08:00 ET
|
Biostem Technologies
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
BioStem Technologies Granted Prioritized Examination for Wound Healing Patent
May 06, 2024 08:00 ET
|
Biostem Technologies
BioStem Technologies Granted Prioritized Examination for Wound Healing Patent
BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts
April 30, 2024 08:30 ET
|
Biostem Technologies
BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts
BioStem Technologies to Present at the 2024 Planet MicroCap Showcase
April 25, 2024 08:00 ET
|
Biostem Technologies
BioStem Technologies to Present at the 2024 Planet MicroCap Showcase
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange
April 24, 2024 08:00 ET
|
Biostem Technologies
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange